Published in Virology on June 05, 1999
Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol (2000) 8.28
Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol (2003) 5.11
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71
Infection of human airway epithelium by human and avian strains of influenza a virus. J Virol (2006) 3.02
Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem (2010) 2.65
Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J Virol (2010) 2.38
Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants. J Virol (2004) 1.73
Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. J Virol (2005) 1.70
MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. J Clin Microbiol (2008) 1.59
Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. PLoS Pathog (2010) 1.57
Evolutionary trends of A(H1N1) influenza virus hemagglutinin since 1918. PLoS One (2009) 1.40
Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing. BMC Genomics (2015) 1.38
Crystal structure of unliganded influenza B virus hemagglutinin. J Virol (2008) 1.24
Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs. J Virol (2010) 1.21
The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells. J Virol (2007) 1.13
Structural basis for receptor specificity of influenza B virus hemagglutinin. Proc Natl Acad Sci U S A (2007) 1.10
The contrasting phylodynamics of human influenza B viruses. Elife (2015) 1.10
A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J (2010) 1.09
Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets. J Virol (2010) 1.08
Development of high-yield influenza A virus vaccine viruses. Nat Commun (2015) 1.08
Genetic and phylogenetic analyses of influenza A H1N1pdm virus in Buenos Aires, Argentina. J Virol (2010) 1.07
Analysis of influenza virus hemagglutinin receptor binding mutants with limited receptor recognition properties and conditional replication characteristics. J Virol (2011) 1.01
Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. Proc Jpn Acad Ser B Phys Biol Sci (2012) 1.00
Detection of hemagglutinin variants of the pandemic influenza A (H1N1) 2009 virus by pyrosequencing. J Clin Microbiol (2011) 0.96
Detecting patches of protein sites of influenza A viruses under positive selection. Mol Biol Evol (2012) 0.95
Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice. Respir Res (2009) 0.92
Compensatory evolution of net-charge in influenza A virus hemagglutinin. PLoS One (2012) 0.91
Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs. Clin Vaccine Immunol (2012) 0.89
Analysis of N-glycans in embryonated chicken egg chorioallantoic and amniotic cells responsible for binding and adaptation of human and avian influenza viruses. Glycoconj J (2008) 0.88
Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y. Antimicrob Agents Chemother (2014) 0.88
Diversifying selective pressure on influenza B virus hemagglutinin. J Med Virol (2009) 0.87
Influenza A virus infection of primary differentiated airway epithelial cell cultures derived from Syrian golden hamsters. Virology (2006) 0.87
Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs. J Virol (2013) 0.87
The receptor preference of influenza viruses. Influenza Other Respir Viruses (2010) 0.85
Infectivity studies of influenza virus hemagglutinin receptor binding site mutants in mice. J Virol (2008) 0.84
Search for additional influenza virus to cell interactions. Glycoconj J (2006) 0.83
The infection of primary avian tracheal epithelial cells with infectious bronchitis virus. Vet Res (2009) 0.82
Technology Resource, Distribution, and Development Characteristics of Global Influenza Virus Vaccine: A Patent Bibliometric Analysis. PLoS One (2015) 0.81
Tropism of Pandemic 2009 H1N1 Influenza a Virus. Front Microbiol (2012) 0.81
Limited Antigenic Diversity in Contemporary H7 Avian-Origin Influenza A Viruses from North America. Sci Rep (2016) 0.79
Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors. Glycoconj J (2010) 0.79
Optimization of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses. Influenza Other Respir Viruses (2015) 0.78
Detection of influenza antigenic variants directly from clinical samples using polyclonal antibody based proximity ligation assays. Virology (2014) 0.78
Rapid estimation of binding activity of influenza virus hemagglutinin to human and avian receptors. PLoS One (2011) 0.78
Gene silencing of β-galactosamide α-2,6-sialyltransferase 1 inhibits human influenza virus infection of airway epithelial cells. BMC Microbiol (2014) 0.78
Gangliosides are not essential for influenza virus infection. Glycoconj J (2006) 0.77
Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses. J Gen Virol (2016) 0.77
The roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virus. Virology (2013) 0.76
Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates. Virology (2015) 0.76
Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses. PLoS Pathog (2016) 0.76
Iminosugars: Promising therapeutics for influenza infection. Crit Rev Microbiol (2016) 0.75
Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs. PLoS One (2015) 0.75
Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells. PLoS One (2016) 0.75
A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor. Cell Rep (2017) 0.75
Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology (1997) 4.96
5' and 3' terminal nucleotide sequences of the RNA genome segments of influenza virus. Nucleic Acids Res (1979) 4.90
Polyadenylation sites for influenza virus mRNA. J Virol (1981) 4.42
Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis (2001) 3.69
Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol (2000) 3.54
Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis (1998) 3.47
Differences in the biological phenotype of low-yielding (L) and high-yielding (H) variants of swine influenza virus A/NJ/11/76 are associated with their different receptor-binding activity. Virology (1998) 3.09
Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology (1985) 2.71
Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology (1987) 2.58
Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA? Cell (1983) 2.42
MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med (1999) 2.41
Partial structural analysis of the oligosaccharide moieties of the vesicular stomatitis virus glycoprotein by sequential chemical and enzymatic degradation. Virology (1977) 2.36
A solid-phase enzyme-linked assay for influenza virus receptor-binding activity. J Virol Methods (1992) 2.32
Specific changes in the oligosaccharide moieties of VSV grown in different lectin-resistnat CHO cells. Cell (1978) 2.30
Structure of the host-derived sequences present at the 5' ends of influenza virus mRNA. Nucleic Acids Res (1980) 2.14
The properties of three baculoviruses from closely related hosts. Virology (1977) 1.93
Duration of survival in traffic accident fatalities. Med J Aust (1968) 1.85
Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs. Virology (1998) 1.60
Glycosylation sites of vesicular stomatitis virus glycoprotein. J Virol (1976) 1.50
MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med (1999) 1.44
Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses. Virology (1993) 1.39
Intestinal transit of solid and liquid components of a meal in health. Gastroenterology (1984) 1.39
Facial reanimation after acoustic neuroma excision: the patient's perspective. Laryngoscope (1991) 1.39
Control of falciparum malaria. Public Health (1992) 1.39
Screening for toxoplasmosis. Public Health (1990) 1.38
H5N1 chicken influenza viruses display a high binding affinity for Neu5Acalpha2-3Galbeta1-4(6-HSO3)GlcNAc-containing receptors. Virology (2004) 1.34
Sequence analysis of the haemagglutinin of A/Taiwan/1/86, a new variant of human influenza A(H1N1) virus. J Gen Virol (1987) 1.34
Codominant mixtures of viruses in reference strains of influenza virus due to host cell variation. Virology (1994) 1.28
Demonstration of the "5-8 S" ribosomal sequence in HeLa cell ribosomal precursor RNA. J Mol Biol (1974) 1.27
Differences between HA receptor-binding sites of avian influenza viruses isolated from Laridae and Anatidae. Avian Dis (2003) 1.26
Differences between influenza virus receptors on target cells of duck and chicken and receptor specificity of the 1997 H5N1 chicken and human influenza viruses from Hong Kong. Avian Dis (2003) 1.26
The metabolism of the isomeric decalones. Biochem J (1966) 1.26
Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. Virology (1989) 1.20
Nomenclature for tracer kinetics. Int J Appl Radiat Isot (1968) 1.20
The metabolism of cis- and trans-decalin. Biochem J (1966) 1.19
Intergenic HA-NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes. Virus Res (2000) 1.19
Interpretation of electronically determined macrocytosis. Ann Intern Med (1973) 1.18
Analysis of separate isolates of Bordetella pertussis repeated DNA sequences. J Gen Microbiol (1989) 1.18
Ventriculoperitoneal shunting for hydrocephalus. Br Med J (1973) 1.18
Icosahedral cytoplasmic deoxyriboviruses. J Gen Virol (1973) 1.17
Baculovirus morphogenesis: the acquisition of the virus envelope. J Invertebr Pathol (1974) 1.17
New procedure for the production of influenza virus-specific double-stranded DNA's. Nucleic Acids Res (1979) 1.16
Water sodium, hypertension and mortality. Community Med (1979) 1.12
Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells. Virology (1999) 1.09
The kidney in progressive systemic sclerosis: a prospective study. Ann Intern Med (1978) 1.08
The MIRD perspective 1999. Medical Internal Radiation Dose Committee. J Nucl Med (1999) 1.03
Relationship of encephalomyocarditis virus to cricket paralysis virus of insects. Intervirology (1984) 1.01
Improved parameter estimates in drug-protein binding studies by non-linear regression. J Pharm Pharmacol (1974) 1.01
Antigenic and molecular characterization of host cell-mediated variants of equine H3N8 influenza viruses. J Gen Virol (1994) 0.98
Metabolism of camphors and related compounds. Biochem J (1969) 0.96
Metabolism of methyldecalins. Biochem J (1970) 0.96
Nucleotide sequences from the non-conserved region of HeLa cell 32-S ribosomal precursor RNA. Biochim Biophys Acta (1973) 0.94
The influence of the host cell on standardisation of influenza vaccine potency. Dev Biol Stand (1999) 0.94
[The effect of losing glycosylation sites near the receptor-binding region on the receptor phenotype of the human influenza virus H1N1]. Mol Biol (Mosk) (2003) 0.92
Analysis of the restriction to the growth of nonegg-adapted human influenza virus in eggs. Virology (1993) 0.91
Polymer-bound 6' sialyl-N-acetyllactosamine protects mice infected by influenza virus. Antiviral Res (2005) 0.91
Distribution and dosimetry of 111In-labeled platelets. Radiology (1981) 0.89
Direct sequencing of the HA gene of clinical equine H3N8 influenza virus and comparison with laboratory derived viruses. Arch Virol (1998) 0.87
[Differences in receptor specificity between the influenza A viruses isolated from the duck, chicken, and human]. Mol Biol (Mosk) (2002) 0.87
The district community physician. Public Health (1975) 0.87
Reactions between an insect picornavirus and naturally occurring IgM antibodies in several mammalian species. Nature (1973) 0.86
Human influenza virus recognition of sialyloligosaccharides. FEBS Lett (1995) 0.86
Vaccines against H5N1 influenza. Vaccine (1999) 0.86
Mortality and hardness of water. Lancet (1968) 0.86
Altered sex ratio after an outbreak of hepatitis. Lancet (1973) 0.85
Synthetic polymeric inhibitors of influenza virus receptor-binding activity suppress virus replication. Antiviral Res (1994) 0.85
Radiation dose in the selection of 131I or surgical treatment for toxic thyroid adenoma. Ann Intern Med (1978) 0.85
Pathology of radiation myelopathy. J Neurol Neurosurg Psychiatry (1972) 0.84
Sequence analysis of the hemagglutinin of B/Ann Arbor/1/86, an epidemiologically significant variant of influenza B virus. Virology (1988) 0.84
Plasma renin activity (PRA) in 89 patients on regular haemodialysis. Proc Eur Dial Transplant Assoc (1972) 0.83
Computer applications in nuclear medicine. J Chronic Dis (1966) 0.83
Pollution of underground water from pea silage. Mon Bull Minist Health Public Health Lab Serv (1966) 0.83
Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism. J Nucl Med (1976) 0.82
Radiobiological aspects of the supersonic transport. Health Phys (1966) 0.82
Periodic oscillation of blood leukocytes, platelets, and reticulocytes in a patient with chronic myelocytic leukemia. Blood (1976) 0.82
Physics and Physiology of Neutron-Capture Therapy. Proc Natl Acad Sci U S A (1954) 0.82
Chemical disasters, real and suspected. Public Health (1993) 0.81
Preparation of vaccines against H5N1 influenza. Vaccine (2002) 0.81
Reverse transcriptase activity in vaccines derived from chick cells. Biologicals (1996) 0.81
Sequence analysis of fowl plague virus mutant ts47 reveals a nonsense mutation in the NS1 gene. Virology (1983) 0.81
Effect of absorption edge filters on diagnostic x-ray spectra. Radiology (1975) 0.81
Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection. Antiviral Res (2002) 0.81
Host cell-dependent differences in the oligosaccharide moieties of the VSV G protein. J Gen Virol (1981) 0.81
The haemagglutinins of influenza A (H1N1) viruses in the 'O' or 'D' phases exhibit biological and antigenic differences. Epidemiol Infect (1993) 0.80
Chronic toxoplasmosis with negative dye test? Postgrad Med J (1966) 0.80
A modern malaise. Public Health (1999) 0.80
A tissue-equivalent ionization chamber for inphantom dosimetry: comparison of measured values with calculated values. Health Phys (1966) 0.80
Metabolism of perhydroanthracenes in the rabbit. Biochem J (1971) 0.80
A whole-body counter with an invariant response to radionuclide distribution and body size. Phys Med Biol (1969) 0.80
Analysis of the chromosomal location of two copies of a Bordetella pertussis insertion sequence. Mol Microbiol (1989) 0.79
Zinc supplementation during pregnancy. J Public Health Med (1991) 0.79
Dosimetry of californium 252. Radiology (1972) 0.79
Listeriosis and perinatal mortality. Mon Bull Minist Health Public Health Lab Serv (1966) 0.79
Summary and conclusion. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals. Dev Biol Stand (1999) 0.79
The antigenic structure of a human influenza A (H1N1) virus isolate grown exclusively in MDCK cells. J Gen Virol (1990) 0.79